Context Matters Featured in Pharmaceutical Commerce

A case study in differing approaches to reimbursement approval in Europe and the US

Our recent op-ed piece for Pharmaceutical Commerce takes an expanded look at the differences between England's National Institute for Health and Care Excellence (NICE) and the US Senate Committee in their approach to evaluating "cost" and "value" of controversial hepatitis C drug Sovaldi.